BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18720096)

  • 61. Statins and aortic stenosis progression: are biologic targets still an option?
    Pai RG
    Curr Cardiol Rep; 2005 Nov; 7(6):399-400. PubMed ID: 16256007
    [No Abstract]   [Full Text] [Related]  

  • 62. Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis.
    Loomba RS; Arora R
    Am J Ther; 2010; 17(4):e110-4. PubMed ID: 19417587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.
    Rajamannan NM; Greve AM; Moura LM; Best P; Wachtell K
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):355-67. PubMed ID: 25797901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renin-angiotensin system inhibition for aortic stenosis "A II, Bruté?".
    Aurigemma GP; Keaney JF
    J Am Coll Cardiol; 2011 Aug; 58(6):577-80. PubMed ID: 21798418
    [No Abstract]   [Full Text] [Related]  

  • 65. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography.
    Antonini-Canterin F; Corrado G; Faggiano P; Popescu BA; Carerj S; La Carrubba S; Zuppiroli A; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2006 Jul; 7(7):464-9. PubMed ID: 16801806
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?
    Parolari A; Tremoli E; Cavallotti L; Trezzi M; Kassem S; Loardi C; Veglia F; Ferrari G; Pacini D; Alamanni F
    Heart; 2011 Apr; 97(7):523-9. PubMed ID: 21270077
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Current Problems in Cardiology. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2010 Jun; 35(6):281. PubMed ID: 20451758
    [No Abstract]   [Full Text] [Related]  

  • 69. [Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?].
    Kaden JJ; Haghi D; Vocke DC; Brueckmann M; Süselbeck T; Borggrefe M
    Med Klin (Munich); 2005 Jun; 100(6):334-9. PubMed ID: 15968485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.
    di Sciascio G
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():41-3. PubMed ID: 18001321
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic effect of statin on aortic stenosis: a review with meta-analysis.
    Ge H; Zhang Q; Wang BY; He B
    J Clin Pharm Ther; 2010 Aug; 35(4):385-93. PubMed ID: 20831541
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease.
    Grande-Allen KJ; Osman N; Ballinger ML; Dadlani H; Marasco S; Little PJ
    Cardiovasc Res; 2007 Oct; 76(1):19-28. PubMed ID: 17560967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statins for progression of aortic valve stenosis and the best evidence for making decisions in health care.
    Thiago L; Tsuj SR; Atallah AN; Puga ME; de Góis AF
    Sao Paulo Med J; 2011 Jan; 129(1):41-5. PubMed ID: 21437508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcific aortic stenosis: another face of atherosclerosis?
    Novaro GM; Griffin BP
    Cleve Clin J Med; 2003 May; 70(5):471-7. PubMed ID: 12779138
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reassessment of statins to retard the progression of aortic stenosis.
    Rajamannan NM
    Curr Cardiol Rep; 2007 Apr; 9(2):99-104. PubMed ID: 17430676
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do statins delay the progression of aortic stenosis?
    Takagi H; Kawai N; Umemoto T
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):e6-9. PubMed ID: 19154890
    [No Abstract]   [Full Text] [Related]  

  • 79. Aortic stenosis and statins.
    Vedamurthy D; Molnar J; Arora R
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1254-5; author reply 1255. PubMed ID: 19837226
    [No Abstract]   [Full Text] [Related]  

  • 80. Prevention of cardiovascular disease in chronic kidney disease patients.
    Wanner C
    Semin Nephrol; 2009 Jan; 29(1):24-9. PubMed ID: 19121471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.